Clients knowledge, attitude and practices on hydration, presenting hydrationstatus and pharmacist’s intervention while requesting prescribed drugs
Keywords:
Hydration status, dehydration, biopharmaceutics, drug disposition, lifestyle practicesAbstract
This study examined the relationship between hydration status and prescription drug requestsamong clients attending a Pharmaceutical Care Clinic in Ikot Ekpene, Nigeria. A cross-sectionaldesign involving 443 consenting adults utilized a three-part methodology: a structuredquestionnaire assessing knowledge, attitudes, and practices (KAP) related to hydration; oralinterviews to collect medical and prescription histories; and laboratory analysis of hydrationindicators. The questionnaire, based on modified validated tools, tested knowledge (maximumscore = 27), attitude (Likert scale), and lifestyle practices, with categorization into poor, fair, orgood knowledge and positive or negative attitudes. Daily fluid intake and 24-hour urine output wererecorded over three days, alongside measurements of urine volume, weight, specific gravity, andosmolality. Blood osmolality was also assessed. Out of 443 approached, 380 respondents (56.1%female, mean age 49.5 ± 6.2 years) completed the study. Knowledge scores were fair overall, withsignificantly higher mean scores among males and those with higher educational attainment(p<0.05). Positive attitudes toward hydration correlated with younger age and tertiary education.Lifestyle practices revealed that males consumed more water post-meal and during the day(p<0.05), while older adults showed reduced water intake. Laboratory findings indicated aconsistent gap between mean daily fluid intake (approx. 3.5 L) and urine output (approx. 2 L), withmales exhibiting higher values. These gender- and education-linked differences in hydrationbehavior may have pharmacokinetic implications, particularly for renally-excreted drugs. Findingssuggest a need for hydration-focused patient counseling in pharmacy settings to optimizetherapeutic outcomes and minimize adverse drug events.